Experimental gene therapy for brain tumors using adenovirus-mediated transfer of cytosine deaminase gene and uracil phosphoribosyltransferase gene with 5-fluorocytosine

Human Gene Therapy

Volumn 11, Issue 1, 2000, Pages 77-89

  Adachi, Yoshiaki ^a   Tamiya, Takashi ^a   Ichikawa, Tomotsugu ^a   Terada, Kin'ya ^a   Ono, Yasuhiro ^a   Matsumoto, Kengo ^a   Furuta, Tomohisa ^a   Hamada, Hirofumi ^b   Ohmoto, Takashi ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b CANCER CHEMOTHERAPY CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE DEAMINASE; FLUCYTOSINE; FLUOROURIDINE; URACIL PHOSPHORIBOSYLTRANSFERASE; VIRUS VECTOR;

ADENOVIRUS; ANIMAL CELL; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BRAIN TUMOR; CHEMOSENSITIVITY; CONTROLLED STUDY; CYTOTOXICITY; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RAT; SUICIDE GENE;

ADENOVIRIDAE; ANIMALS; BRAIN NEOPLASMS; CYTOSINE DEAMINASE; FLUCYTOSINE; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; MAGNETIC RESONANCE IMAGING; NUCLEOSIDE DEAMINASES; PENTOSYLTRANSFERASES; RATS; RECOMBINATION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0033958068     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430340050016175     Document Type: Article

References (40)

1. Andersen, P.S., Smith, J.M., and Mygimd, B. (1992). Characterization of the upp gene encoding uracil phosphoribosyltransferase of Escherichia coli K12. Eur. J. Biochem. 204, 51-56.
2. Boviatsis, E.J., Chase, M., Wei, M.X., Tamiya, T., Hurtford, R.K., JR., Kowall, N.W., Tepper, R.I., Breakefield, X.O., and Chiocca, E.A. (1994). Gene transfer into experimental brain tumors mediated by adenovirus, herpes simplex virus, and retrovirus vectors. Hum. Gene Ther. 5, 183-191.
3. Calabrisi, P., and Chabner, B.A. (1990). Antineoplastic agents. In Goodman and Gilman's the Pharmacological Basis of Therapeutics, 8th Ed. A.G. Gilman, T. Rall, A.S. Nies, and P. Taylor, eds. (Pergamon Press, New York) pp. 1209-1263.
4. Cao, X., Ju, D.W., Tao, Q., Wang, J., Wan, T., Wang, B.M., Zhang, W., and Hamada, H. (1998). Adenovirus-mediated GM-CSF gene and cytosine deaminase gene transfer followed by 5-fluorocytosine administration elicit more potent antitumor response in tumor-bearing mice. Gene Ther. 5, 1130-1136.
5. Culver, K.W., Ram, Z., Wallbridge, S., Ishii, H., Oldfield, E.H., and Blaese, R.M. (1992). In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 256, 1550-1552.
6. Dilber, M.S., Abedi, M.R., Christensson, B., Bojorkstrand, B., Kidder, G.M., Naus, C.C.G., Gahrton, GS., and Smith, C.I.E. (1997). Gap junctions promote the bystander effect of herpes simplex virus thymidine kinase in vivo. Cancer Res. 57, 1523-1528.
7. Dong, Y., Wen, P., Manome, Y., Parr, M., Hirshowitz, A., Chen, L., Hirshowitz, E.A., Crystal, R., Weichselbaum, R., Kufe, D.W., and Fine, H.A. (1996). In vivo replication-deficient adenovirus vector - mediated transduction of the cytosine deaminase gene sensitizes glioma cells to 5-fluorocytosine. Hum. Gene Ther. 7, 713-720.
8. Freytag, S.O., Rogulski, K.R., Paielli, D.L., Gilbert, J.D., and Kim, J.H. (1998). A novel three-pronged approach to kill cancer cells selectively: Concomitant viral, double suicide gene, and radiotherapy. Hum. Gene Ther. 9, 1323-1333.
9. Ghattas, I.R., Sanes, J.R., and Majore, J.E. (1991). The encephalomyocarditis virus internal ribosomal entry site allows efficient co-expression of two genes from a recombinant provirus in cultured cells and in embryos. Mol. Cell Biol. 11, 5848-5859.
10. Hirshowitz, E.A., Ohwada, A., Pascal, W.R., Russi, T.J., and Cristal, R.G. (1995). In vivo adenovirus-mediated gene transfer of the Escherichia coli cytosine deaminase gene to human colon carcinoma-derived tumors induced chemosensitivity to 5-fluorocytosine. Hum. Gene Ther. 6, 1055-1063.
11. Huber, B.E., Austin, E.A., Good, S.S., Knick, V.C., Tibbels, S., and Richards, C.A. (1993). In vivo antitumor activity of 5-fluorocytosine on human colorectal carcinoma cells genetically modified to express cytosine deaminase. Cancer Res. 53, 4619-4626.
12. Ichikawa, T., Tamiya, T., Adachi, Y., Ono, Y., Matsumoto, K., Yoshida, Y., Hamada, H., and Ohmoto, T. (1999) In vivo efficacy and toxicity of 5-fluorocytosine/cytosine deaminase gene therapy for malignant gliomas mediated by adenovirus. Cancer Gene Ther., in press.
13. Jerome, V., and Muller, R. (1998). Tissue-specific, cell cycle-regulated chimeric transcription factors for the targeting of gene expression to tumor cells. Hum. Gene Ther. 9, 2653-2659.
14. Kanai, F., Lan, K.-H., Shiratori, Y., Tanaka, T., Ohashi, M., Okudaira, T., Yoshida, Y., Wakimoto, H., Hamada, H., Nakabayashi, H., Tamaoki, T., and Omata, M. (1997). In vivo gene therapy for alfa-fetoprotein-producing hepatocellular carcinoma by adenovirus-mediated transfer of cytosine deaminase gene. Cancer Res. 57, 461-465.
15. Kanai, F., Kawakami, T., Hamada, H., Sadata, A., Yoshida, Y., Tanaka T., Ohashi, M., Tateishi, K., Shiratori, Y., and Omata, M. (1998). Adenovirus-mediated transduction of Escherichia coli uracil phosphoribosyltransferase gene sensitizes cancer cells to low concentration of 5-fluorouracil. Cancer Res. 58, 1946-1951.
16. Kanegae, Y., Lee, G., Sato, Y., Tanaka, M., Nakai, M., Sakai, M., and Saito, I. (1995). Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase. Nucleic Acids Res. 23, 3816-3821.
17. Lan, K.-H., Kanai, F., Shiratori, Y., Ohashi, M., Tanaka, T., Okudaira, T., Yoshida, Y., Hamada, H., and Omata, M. (1997). In vivo selective gene expression and therapy mediated by adenoviral vectors for human carcinoembryonic antigen-producing gastric carcinoma. Cancer Res. 57, 4279-4284.
18. Manome, Y., Abe, M., Hagen, M.F., Fine, H.A., and Kufe, D.W. (1994). Enhancer sequences of the DF3 gene regulate expression of the herpes simplex virus thymidine kinase gene and confer sensitivity of human breast cancer cells to ganciclovir. Cancer Res. 54, 5408-5413.
19. Masuike, T., Watanabe, I., and Takemoto, Y. (1985). Quantitative method of 5-fluorouracil and its metabolites in biological samples using high performance liquid chromatography. Yakugaku Zasshi 105, 1058-1064.
20. Masuike, T., Kikuchi, K., Saito, A., Hashimoto, T., and Takemoto, Y. (1995). Determination of 5-fluorouracil incorporated into RNA in tissue using gas chromatography-mass spectrometry. Antibiot. Chemother. 11, 162-167.
21. Miyao, Y., Shimizu, K., Moriuchi, S., Yamada M., Nakahira, K., Nakajima, K., Nakao, J., Kuriyama, S., Tsuji, T., Mikosiba, K., Hayakawa, T., and Ikenaka, K. (1993). Selective expression of foreign genes in glioma cells: Use of the mouse basic protein gene promoter to direct toxic gene expression. J. Neurosci. Res. 36, 472-479.
22. Mizushima, Y., and Miyamoto, T. (1997). Today's Therapeutic Drugs, 19th Ed. (Nankoudou, Tokyo, Japan) p. 95.
23. Moolten, F.L., Wells, J.M., Heyman, R.A., and Evans, R.M. (1990). Lymphoma regression induced by ganciclovir in mice bearing a herpes thymidine kinase transgene. Hum. Gene Ther. 1, 125-134.
24. Morgan, R.A., Couture, L., Elroy-Stein, O., Ragheb, J., Moss, B., and Anderson, W.F. (1992). Retroviral vectors containing putative internal ribosome entry sites; development of a polycistronic gene transfer system and applications to human gene therapy. Nucleic Acids Res. 20, 1293-1299.
25. Mullen, C.A. (1992). Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: A negative selection system. Proc. Natl. Acad. Sci. U.S.A. 89, 33-37.
26. Nishiyama, T., Kawamura, Y., Kawamoto, K., Matsumura, H., Yamamoto, N., Ito, T., Ohyama, A., Katsuragi, T., and Sakai, T. (1985). Antineoplastic effects in rats of 5-fluorocytosine in combination with cytosine deaminase capsules. Cancer Res. 45, 1753-1761.
27. Niwa, H., Yamamura, K., and Miyazaki, J. (1991). Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108, 193-200.
28. Ohwada, A., Hirshowitz, E.A., and Cristal, R.G. (1996). Regional delivery of an adenovirus vector containing the Escherichia coli cytosine deaminase gene to provide local activation of 5-fluorocytosine to suppress the growth of colon carcinoma metastatic to liver. Hum. Gene Ther. 7, 1567-1576.
29. Oldfield, E.H., Ram, Z., Culver, K.W., Blaese, R.M., Devroom H.L., and Anderson, W.F. (1993). Gene therapy for the treatment of brain tumors using intratumoral transduction with the thymidine kinase gene and intravenous ganciclovir. Hum. Gene Ther. 4, 39-69.
30. Ono, Y., Ikeda, K., Wei, M.X., Harsh, G.R., Tamiya, T., and Chiocca, E.A. (1997). Regression of experimental brain tumors with 6-thioxanthine and Escherichia coli gpt gene therapy. Hum. Gene Ther. 8, 2043-2055.
31. Rogulski, K.R., Kim, J.H., Kim, S.H., and Freytag, S.O. (1997). Glioma cells transduced with an Escherichia coli CD/HSV-1 TK fusion gene exhibit enhanced metabolic suicide and radiosensitivity. Hum. Gene Ther. 8, 73-85.
32. Takamiya, Y., Short, M.P., Moolten, F.L., Fleet, C., Mineta, T., Breakefield, X.O., and Martuza, R.L. (1993). An experimental model of retrovirus gene therapy for malignant brain tumors. J. Neurosurg. 79, 104-110.
33. Tamiya, T., Wei, M.X., Chase, M., Ono, Y., Lee, F., Breakefield, X.O., and Chiocca, E.A. (1995). Transgene inheritance and retroviral infection contribute to the efficacy of gene expression in solid tumors inoculated with retroviral vector producer cells. Gene Ther. 2, 531-538.
34. Tamiya, T., Ono, Y., Wei, M.X., Morz, P.J., Moolten, F.L., and Chiocca, E.A. (1996). Escherichia coli gpt gene sensitizes rat glioma cells to killing by 6-thioxanthine or 6-thioguanine. Cancer Gene Ther. 3, 155-162.
35. Tanaka, T., Kanai, F., Okabe, S., Yoshida, Y., Wakimoto, H., Hamada H., Shiratori, Y., Lan, K.H., Ishitobi, M., and Omata, M. (1996). Adenovirus-mediated prodrug gene therapy for carcinoembryonic antigen-producing human gastric carcinoma cells in vitro. Cancer Res. 56, 1342-1345.
36. Tiraby, M., Cazaux, C., Baron, M., Drocourt, D., Reynes, J.P., and Tiraby, G. (1998). Concomitant expression of E. coli cytosine deaminase and uracil phosphoribosyltransferase improves the cytotoxicity of 5-fluorocytosine. FEMS Microbiol. Lett. 167, 41-49.
37. Topf, N., Worgall, S., Hackett, N.R., and Crystal, R.G. (1998). Regional "pro-drug" gene therapy: Intravenous administration of an adenoviral vector expressing the E. coli cytosine deaminase gene and systemic administration of 5-fluorocytosine suppresses growth of hepatic metastasis of colon carcinoma. Gene Ther. 5, 507-513.
38. Wakimoto, H., Yoshida, Y., Aoyagi, M., Hirakawa, K., and Hamada, H. (1997). Efficient retrovirus-mediated cytokinegene transduction of primary cultured human glioma cells for tumor vaccination therapy. Jpn. J. Cancer Res. 88, 296-305.
39. Wei, M.X., Tamiya, T., Chase, M., Boviatsis, E.J., Chang, T.K.H., Kowall, N.W., Hochberg, F.H., Waxman, D.J., Breakfield, X.O., and Chiocca, E.A. (1994). Experimental tumor therapy in mice using the cyclophosphamide-activating cytochrome P450 gene. Hum. Gene Ther. 5, 969-978.
40. Wei, M.X., Tamiya, T., Rhee, R.J., Breakfield, X.O., and Chiocca, E.A. (1995). Diffusible cytotoxic metabolites contribute to the in vitro bystander effect associated with the cyclophosphamide/cytochrome P450 2B1 cancer gene therapy paradigm. Clin. Cancer Res. 1, 1171-1177.